companydata.dkcompanydata.dk

GLAXOSMITHKLINE PHARMA A/S: Financial statements 2015

CVR: 27394019

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2015. In 2015, the company reported revenue of DKK 338,938,000 and a net result of DKK 3,665,000 compared with DKK 11,764,000 the year before. That is a decrease of 8.8% compared with the year before. The profit margin was 1.1%. Equity in the 2015 report amounted to DKK 147,935,000. The solvency ratio was 62.7%. The company had 87 employees in the financial year.

Revenue
DKK 338,938,000
Gross Profit
DKK 111,744,000
Profit/Loss
DKK 3,665,000
Equity
DKK 147,935,000
Total Assets
DKK 235,844,000
Employees
87

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015338.9 mio.111.7 mio.3.7 mio.147.9 mio.87
2014371.5 mio.119.2 mio.11.8 mio.144.3 mio.92
2013364.3 mio.127 mio.14.5 mio.146.9 mio.109

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is GLAXOSMITHKLINE PHARMA A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

Josephine Yang Comiskey joins the board of GLAXOSMITHKLINE PHARMA A/SDec 2, 2015

As of December 2, 2015, Josephine Yang Comiskey has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.

Judith Lynne Stewart leaves the board of GLAXOSMITHKLINE PHARMA A/SDec 2, 2015

As of December 2, 2015, Judith Lynne Stewart has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.

Josephine Yang Comiskey joins GLAXOSMITHKLINE PHARMA A/S as adm. dir.Dec 2, 2015

As of December 2, 2015, Josephine Yang Comiskey is registered as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.

Judith Lynne Stewart steps down as adm. dir. of GLAXOSMITHKLINE PHARMA A/SDec 2, 2015

As of December 2, 2015, Judith Lynne Stewart has stepped down as adm. dir. of GLAXOSMITHKLINE PHARMA A/S.

GLAXOSMITHKLINE PHARMA A/S: The 2014 annual report is outJun 4, 2015

GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2014. Revenue came to DKK 371,489,000, and the net result was DKK 11,764,000.

Daniël Gijbels joins the board of GLAXOSMITHKLINE PHARMA A/SMay 26, 2015

As of May 26, 2015, Daniël Gijbels has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.

Birgit Yvonne Reimann leaves the board of GLAXOSMITHKLINE PHARMA A/SMay 26, 2015

As of May 26, 2015, Birgit Yvonne Reimann has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.

Registered as owner of GLAXOSMITHKLINE PHARMA A/SFeb 20, 2015

As of February 20, 2015, is registered as an owner of GLAXOSMITHKLINE PHARMA A/S with an ownership share of 100%.

About GLAXOSMITHKLINE PHARMA A/S

GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.

Source: annual report 2025, Danish Business Authority